TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 3 | -1 | -2 | -24 | 22 | 2 | 0 | -1 |
P | %wins | 33 | 33 | 0 | 67 | 50 | 100 | 47 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/30/16 18:59 | 11/29/16 | CLRB | Cellectar Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Neis John | WI | D | P.d | 497 | 1.49 | 1 | 333 | 112 | 631 | I | -94 | -86 | -51 | -33 | -28 | -8 | -41 | 4 | -4 | -5 | -14 | 46 | |||
4/21/16 18:03 | 4/20/16 | CLRB | Cellectar Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Neis John | WI | D | P.d | 498 | 2.12 | 0 | 235 | 371 | 298 | I | -97 | -94 | -90 | -59 | -58 | -40 | -46 | -2 | -2 | -7 | -41 | 33 | 12 | ||
8/22/14 17:21 | 8/20/14 | CLRB | Cellectar Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Neis John | WI | D | P.d | 1,008 | 3.75 | 0 | 269 | 74 | 632 | I | -86 | -63 | -64 | -55 | -55 | -57 | -39 | -3 | 4 | 7 | -16 | -14 | -9 | 0 | |
11/9/05 15:25 | 11/8/05 | TWTI | Third Wave Technologies Inc /wi | DE | Health | BioPrd | Biological Products, (No Diag | Neis John | WI | D | P | 13 | 2.68 | 0 | 5 | 0 | 1,887 | D | |||||||||||||||
3/15/05 10:54 | 3/11/05 | TWTI | Third Wave Technologies Inc /wi | DE | Health | BioPrd | Biological Products, (No Diag | Neis John | WI | D | P | 24 | 4.77 | 0 | 5 | 0 | 1,866 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |